Isabelle Michel Ayoub MD FASN
Glomerular Disease, Kidney & Pancreas Transplantation
Assistant Professor of Clinical Medicine
Join to view full profile
543 Taylor AveColumbus, OH 43203
Phone+1 614-293-4837
Fax+1 614-293-3125
Dr. Ayoub is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
SUNY Downstate Health Sciences UniversityFellowship, Nephrology, 2011 - 2013
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2008 - 2011
Lebanese University School of MedicineClass of 2005
Certifications & Licensure
OH State Medical License 2014 - 2027
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016
Clinical Trials
- A Study With Imlifidase in Anti-GBM Disease Start of enrollment: 2022 Dec 22
Roles: Contact
- Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
Roles: Contact
Publications & Presentations
PubMed
- Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Jürgen Floege, Isabelle Ayoub, Silke R Brix, Kirk N Campbell, Richard Furie
Kidney International. 2026-09-01 - Updates on the diagnosis, prognosis, and management of IgA vasculitis in adults: A narrative review.Valerie R Stichert, Breanna Santoso, Bethany G Winters, Sophia Thompson, Isabelle Ayoub
Journal of the American Academy of Dermatology. 2026-08-01 - Front-loading response: why combination therapy should anchor initial lupus nephritis treatment.Juan M Mejia-Vilet, Isabelle Ayoub
Kidney International. 2026-07-29
Press Mentions
New Findings Add to Questions About Existence of Gouty NephropathyJanuary 13th, 2021- Clinical Trials, Non-Drug Studies at the Ohio State University Wexner Medical Center Aim to Slow Kidney Disease ProgressionJanuary 24th, 2021
- New KDOQI Commentary of 2021 KDIGO Clinical Practice Guideline for Glomerular Diseases PublishedJune 23rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
